Silence Therapeutics plc Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure for Q1 2023

Taxonomy & unit
us-gaap: pure
Description
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
Summary
Silence Therapeutics plc annual/quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate for Q1 2023.
  • Silence Therapeutics plc Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending March 31, 2023 was 0.19 pure.
  • Silence Therapeutics plc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2024 was 0.25 pure, a 8.51% increase from 2023.
  • Silence Therapeutics plc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.24 pure, a 21.1% increase from 2022.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 0.19 Jan 1, 2023 Mar 31, 2023 10-K 2025-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.